On Sept. 16, 1977, Andreas Gruentzig, MD, performed the first successful coronary angioplasty in Zurich, Switzerland. With a small balloon catheter, an extraordinary vision and the courage to challenge what was then considered possible, he opened a new chapter in the treatment of coronary artery disease.

What began with one patient and one balloon became a revolution.

Over the nearly five decades that have followed, the field pioneered by balloon angioplasty has evolved into modern PCI through coronary stents, drug-eluting technologies, intravascular imaging, physiology, increasingly sophisticated approaches to complex coronary disease and countless other advances. Millions of patients around the world have benefited from the innovation that followed that first procedure.

But this milestone is about more than celebrating a technology. It is also about celebrating the spirit of innovation that defines cardiovascular medicine.

Gruentzig understood that progress requires curiosity, persistence, collaboration and, sometimes, the courage to challenge conventional wisdom. His work also reminds us that transformational innovation is rarely the achievement of one person alone. It is built upon the discoveries of those who came before us and advanced by generations of clinicians, scientists, engineers, nurses, technologists, trainees and, most importantly, patients willing to participate in the journey.

As ACC President and an interventional cardiologist, this anniversary is especially meaningful to me. I have had the privilege of witnessing firsthand how dramatically our field has evolved and how innovation, when paired with rigorous science and an unwavering commitment to patients, can transform lives.

Yet our responsibility is not simply to celebrate the past, but to imagine the next 49 years. What discoveries being pursued today will seem equally revolutionary in 2075? How will artificial intelligence, precision medicine, new devices and therapeutics, and better approaches to prevention reshape cardiovascular care? And how do we ensure that these advances reach every patient and every community that needs them?

These questions belong to all of us.

Today, I invite our ACC community to honor pioneers like Gruentzig who brought us here and to recognize the innovators among us who are building what comes next.

Innovation begins with believing that better is possible.

Forty-nine years ago, one courageous idea changed cardiovascular medicine forever.

May we never stop pursuing the next one.

Roxana Mehran, MD, FACC
President, American College of Cardiology

Clinical Topics: Cardiovascular Care Team, Invasive Cardiovascular Angiography and Intervention, Atherosclerotic Disease (CAD/PAD), Interventions and Coronary Artery Disease

Keywords: Angioplasty, Balloon, Coronary, Coronary Artery Disease, Switzerland, History, History of Medicine, Innovation, Cardiology, Interventional Cardiology